logo
15:57 Oct 25

Novartis India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
672.25
-17.10 (-2.48%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Novartis India Ltd. Financials

Novartis India Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
672.25
-17.10 (-2.48%)
15:57 Oct 25
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

35/100
Technically Neutral

Strength

8

Weakness

5

Opportunity

0

Threats

0

12.85 %

ROE %

10.64 %

ROA %

43.17

EPS

318.06

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
399.87 378.74 335.07 356.27 354.76
Operating Expenses +
372.76 313.66 269.81 264.85 254.38
Raw Material
187.26 199.34 189.98 199.07 208.76
Increase Decrease in Cost
-9.13 2.35 9.86 3.75 -11.71
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
101.89 35.64 22.96 18.72 18.57
Miscellaneous Expenses
467.26 475.01 426.97 441.45 38.76
Operating Profit
27.11 65.08 65.26 91.42 100.38
Other Income
33.19 58.11 61.68 41.96 41.24
Depreciation
9.65 6.06 2.61 2.19 2.11
Interest
4.83 1.75 1.49 0.77 0.69
Profit before tax and exceptio..
45.82 115.38 122.84 130.42 138.82
Exceptional Items
-49.64 0 0 0 0
PBT
-3.82 115.38 122.84 130.42 138.82
Provision for Taxation
-0.1 12.02 37.65 29.52 32.46
Net Profit
-3.72 103.36 85.19 100.9 106.59
NET Profit after MI
0 0 0 0 0
EPS
-1.51 41.86 34.5 40.87 43.18
Operating Profit Margin (%)
6.78 17.18 19.48 25.66 28.3
Net Profit Margin (%)
-0.93 27.29 25.42 28.32 30.05

Novartis India Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 70.70 70.70 70.70 70.70 70.70 70.70
FII 0.20 0.20 0.20 0.20 0.20 0.20
Public 0.50 0.50 0.50 0.50 0.50 0.50
Others 28.60 28.60 28.60 28.60 28.60 28.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: